搜索结果

• IPG光子公司宣布统一专利法院就针对其的专利案件作出裁决
  来源: https://watch.patwatch.com/featured · 时间: 2026-02-25 23:11
• Enveric Biosciences宣布撤回其专利相关请愿——ENVB股价上涨
  来源: https://watch.patwatch.com/featured · 时间: 2026-02-25 23:11
• Niagen Bioscience获得静脉NAD+前体递送专利
  来源: https://watch.patwatch.com/featured · 时间: 2026-02-25 23:11
• Archer对Vertical提起专利侵权诉讼
  来源: https://watch.patwatch.com/featured · 时间: 2026-02-25 23:11
• Zydus Lifesciences计划在专利到期首日于印度推出司美格鲁肽注射剂
  来源: https://watch.patwatch.com/featured · 时间: 2026-02-25 23:11
• Niagen Bioscience获得烟酰胺核糖新美国专利
  来源: https://watch.patwatch.com/featured · 时间: 2026-02-25 23:11
• IPG光子公司宣布在统一专利法院的裁决结果
  来源: https://watch.patwatch.com/featured · 时间: 2026-02-25 23:11
• 欧洲法院认定IPG激光设计在7个国家侵犯专利
  来源: https://watch.patwatch.com/featured · 时间: 2026-02-25 22:10
• Harbinger收购自动驾驶公司Phantom AI以拓展技术与收入来源
  Electric trucking startup Harbinger has acquired autonomous driving software company Phantom AI, in an effort to vertically integrate more technology and create new revenue streams for the young compa
  来源: https://watch.patwatch.com/featured · 时间: 2026-02-25 22:10
• 宣扬优点：“节省空间”的序言未能限制权利要求范围
  来源: https://watch.patwatch.com/featured · 时间: 2026-02-25 22:10
• Niagen Bioscience获得静脉注射NAD+前体递送专利
  来源: https://watch.patwatch.com/featured · 时间: 2026-02-25 22:10
• 美国新专利涵盖更快的NAD+静脉注射疗法，已应用于1200家诊所
  来源: https://watch.patwatch.com/featured · 时间: 2026-02-25 22:10
• Archer Aviation对Vertical提起专利诉讼 股价盘前上涨
  来源: https://watch.patwatch.com/featured · 时间: 2026-02-25 22:10
• Leveragen在日本获得Singularity平台专利以强化全球知识产权组合
  来源: https://watch.patwatch.com/featured · 时间: 2026-02-25 22:10
• Leveragen在日本获得Singularity平台专利以强化全球知识产权组合
  来源: https://watch.patwatch.com/featured · 时间: 2026-02-25 22:10
• Gilgamesh在艾伯维12亿美元交易后撤回对Enveric的专利诉讼
  来源: https://watch.patwatch.com/featured · 时间: 2026-02-25 22:10
• Melodia Therapeutics宣布获得涵盖MLD-151的美国专利授权
  来源: https://watch.patwatch.com/featured · 时间: 2026-02-25 22:10
• USPTO是否再次对特定专利申请进行额外审查？
  来源: https://watch.patwatch.com/featured · 时间: 2026-02-25 21:09
• USPTO被指重启专利申请额外审查程序 发明人诉至法院
  “The USPTO has no…discretion to flag and indefinitely shelve pending patent applications because someone views them as being of ‘special interest.’” A battle is currently being waged in a federal cour
  来源: https://watch.patwatch.com/featured · 时间: 2026-02-25 21:09
• 印度或迎Ozempic革命？司美格鲁肽专利到期引发仿制药热潮
  来源: https://watch.patwatch.com/featured · 时间: 2026-02-25 21:09